15 August 2023 in Journal of Education, Health and Sport
Energy drinks (NE) are popular stimulants among adolescents and adults. They are commercial, advertised, widely available products that contain increased amounts of caffeine, and are designed to reduce feelings of fatigue in favor of increased mental and physical performance. In addition to caffeine, various ingredients such as vitamins, dyes or substances that impart a certain flavor are added to NEs. Many cases have been described of the harmful effects of NE used alone and in combination with alcohol on the human body: including on the digestive system, central nervous system, cardiovascular system or kidneys. We decided to analyze and compare with each other the composition of NEs from the most popular manufacturers available in most Polish grocery stores. We then briefly described the most important substances available in NE and reviewed the literature on their potential toxicity. It is reasonable for physicians and teachers to educate young people and their parents about the harmfulness of NE, especially when children are suspected of taking large amounts. Further observations and studies monitoring the harmfulness of NEs are needed, and the drinks themselves should be subject to special surveillance.
13 August 2024 in Quality in Sport
Introduction: Nicotinamide mononucleotide (NMN) is a supplement that can boost nicotinamide adenine dinucleotide (NAD+) levels in the body, which is crucial for maintaining energy balance and stress response. Declining NAD+ levels with age contribute to aging and related diseases, making NMN supplementation a potential solution. Despite its potential benefits, NMN’s safety and efficacy need further investigation. Aim of the Study: This study aimed to analyze recent research on NMN supplementation regarding its safety and efficacy in improving human health, especially in patients with diabetes and prediabetes, and to suggest potential research directions for this compound. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, focusing on literature from the past 5 years, primarily on randomized controlled trials. The databases were searched using the term “nicotinamide mononucleotide” to gather articles, and references from selected articles were included. Conclusion: A beneficial direction for NMN research is an in-depth analysis of its effects on skeletal muscles in both healthy individuals and those with diabetes. Studies on larger groups, with higher doses, and over longer periods are crucial to determine the optimal supplementation protocol and assess individual variability in NMN’s metabolic effects.
19 August 2023 in Journal of Education, Health and Sport
Introduction and purpose: Cardiovascular diseases are the leading cause of mortality in many European countries. Major modifiable risk factors include dyslipidemia, hypertension, smoking and diabetes. The aim of our study is to draw attention to the possible impact of the use of anabolic androgenic steroids on increased cardiovascular risk. Brief description of the state of knowledge: Currently, an increasing proportion of the population uses anabolic-androgenic steroids (AAS). This situation applies not only to athletes, but also to amateurs. The use of AAS may be associated with numerous complications. These include an increased risk of cardiovascular disease. The literature describes the effect of AAS use on the occurrence of dyslipidemia, insulin resistance, hypertension and metabolic syndrome. All these metabolic disorders result in increased cardiovascular risk. To prevent complications, it seems best to withdraw AAS gradually under medical supervision to minimize withdrawal effects. Conclusion: The use of AAS may cause cardiovascular disease, but additional long-term studies are needed to prove this. It is necessary to sensitize patients and doctors to the problem of AAS abuse in society, because this issue can become a significant risk factor for cardiovascular diseases in near future.
18 July 2024 in Quality in Sport
Introduction: The present study investigated the role of fasting and diet in the development and treatment of cancers, with a focus on non-Hodgkin’s lymphomas. Dietary components and regimens have an impact on the risk of development of malignances as well as on the treatment of the disease. Cancerous subtypes react differently to various dietary compounds and regimes. Although not widely used- fasting can be valuable help in cancer treatment. In this article we show how diet modifications and restrictions can affect existing therapies. Aim of the study: By analyzing current literature, the study aimed to understand how various dietary components and regimens influence cancer risk and treatment efficacy. Methods: Extensive research was conducted using PubMed and Google Scholar. References from selected articles were included in the analysis. Results: Consuming high amount of fruits and vegetables, unsaturated fats and supplementing vitamin D can reduce the risk of malignancies, with red meat, dairy products and saturated fats intake increasing it. Fasting affects lipid, glucose, protein and neuroendocrine metabolism in the way that helps the treatment of cancers. It slows down tumor growth, reduces some symptoms and improves the effects of chemotherapy. Exploring this topic further could propagate suitable diets for cancer subtypes as well as popularize fasting, which is not yet a widely known adition to standard anti-cancer treatments.
19 August 2023 in Journal of Education, Health and Sport
Introduction and purpose: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women. It is a very complex disease in which hormonal disorders result in a number of metabolic dysfunctions and malfunctioning of the ovaries. This can lead to infertility, miscarriage and an increased risk of endometrial cancer. The aim of our work is to draw attention to the influence of PCOS on increased cardiovascular risk. Brief description of the state of knowledge: The occurrence of PCOS, especially uncontrolled pharmacologically and non-pharmacologically, may be associated with an increased cardiovascular risk. The literature describes a higher incidence of dyslipidemia, carbohydrate metabolism disorders, obesity, hypertension, chronic inflammation and oxidative stress. As a consequence, it can lead to the development of metabolic syndrome. All these factors negatively affect the risk of developing cardiovascular disease. To prevent this, it is necessary to use appropriate pharmacological and non-pharmacological methods in women diagnosed with PCOS. Conclusion: The mechanism of PCOS is complex and its development is influenced by genetic, endocrine, metabolic and environmental factors. The lack of proper diagnosis and the lack of treatment of PCOS is associated with numerous metabolic complications and an increased risk of cardiovascular diseases. Due to the poorly understood pathomechanism of this disease, further long-term studies are needed to help diagnose and treat PCOS.
16 July 2024 in Quality in Sport
Introduction: Dry eye disease (DED) is a prevalent and debilitating ocular condition characterized by discomfort, visual disturbances, and tear film instability. Recent therapeutic developments have introduced perfluorohexyloctane ophthalmic solution (Miebo®) as a potential treatment for DED, particularly in patients with meibomian gland dysfunction (MGD). Aim of the Study: This narrative review aims to evaluate the efficacy and safety of Miebo® in treating DED based on current clinical evidence. Materials and Methods: A comprehensive literature search was conducted in PubMed, Embase, and Cochrane Library databases up to May 2024 resulting in the identification of 9 studies. The review included randomized controlled trials, prospective cohort studies, and systematic reviews that focused on the use of Miebo® for DED. Data on efficacy in improving tear film stability and symptom relief, as well as safety profiles, were extracted and analyzed. Results: The evidence indicates that Miebo® significantly enhances tear film stability and alleviates symptoms of DED, with pronounced benefits observed in patients with MGD. Comparative studies demonstrate that Miebo® is more effective than conventional treatments, such as artificial tears and lipid-based formulations. Safety assessments reveal minimal ocular surface discomfort and no significant systemic adverse events associated with Miebo® use. Conclusion: Miebo® shows substantial efficacy and a favorable safety profile in managing DED, making it a valuable therapeutic option, particularly for patients who do not respond to traditional therapies. However, further research is needed to confirm its long-term effectiveness and safety.